AHNS Meetings and Events
2005
American Head & Neck Society Annual Meeting during the
Combined Otolaryngology Society Meetings (COSM)
May 15-16, 2005 in Boca Raton, FL
Register at http://www.cosm.md/
Program Chair: Jay O. Boyle, MD
President: Patrick Gullane, MD
Sunday May 15th
Oral Session 1: 1:20 pm – 2:10 pm
Oral #: 1 Great Auricular Nerve Morbidity after Sacrifice during Parotidectomy and the Impact on Patients, William Ryan, Palo Alto
Oral #: 2 Impact of Sentinel Node Status and Other Risk Factors on the Clinical Outcomes of Head and Neck Melanoma Patients, Stanley Leong, San Francisco
Oral #: 3 Combined therapy of anaplstic thyroid carcinoma with cetuximab and irinotecan, Seungwon Kim, Houston
Discussion
Oral #: 4 Results of Surgical Salvage After Failure of Definitive Radiation Therapy for Early-Staged Squamous Cell Carcinoma of, Ivan Ganly, New York
Oral #: 5 Voice evaluation in patients submmited to thyroid surgery without recurrent laryngeal nerve injury, Luiz Kowalski, São Paulo
Discussion
Oral Session 2: 4:15 pm – 5:35 pm
Oral #: 6 Serum protein profile analysis in patients with head and neck squamous cell carcinoma, Christine Gourin, Augusta
Oral #: 7 Deregulated expression of FANCA and GSTP1 in oral squamous cell carcinoma of young patients, Suzanne Kamel-Reid, Toronto
Oral #: 8 Gene expression profiling of oral cancer from the UK and Sri Lanka; gene specific changes related to aetiology., Victor Lopes, Birmingham
Discussion
Oral #: 9 Neoadjuvant Chemoradiation W/ Rebiopsy Directed Salvage Surgery Is Associated W/ a High Rate of Laryngeal Preservation, Harold Wanebo, Providence
Oral #: 10 Endoscopic Laser Resection of Tongue Base and Oropharyngeal Wall Carcinoma: Functional and Oncologic Outcomes, Guy Petruzzelli, Maywood
Oral #: 11 Rate of complete pathological responses (pCR) to TPF induction chemotherapy in new diagnosis SCCHN, Robert Haddad, Boston
Oral #: 12 Selective neck dissection for N+ neck in head and neck SCC: a word of caution, based on a preliminary study., Claudio Cernea, São Paulo
Discussion
Monday May 16th
Oral Session 3: 8:00 am – 9:00 am
Oral #: 13 Can cDNA microarray predict nodal metastasis in patients with cancer of the head and neck?, Ehab Hanna, Houston
Oral #: 14 LEKTI Regulates Metalloproteinases and Suppresses Perineral Invasion in HNSCC, Thomas Shellenberger, Houston
Oral #: 15 Three-dimensional analysis of p53 mutations in head and neck squamous cell carcinoma, Christopher Lansford, Ann Arbor
Discussion
Oral #: 16 CpG-motifs as adjuvants for Peptide-based Immunotherapy for HPV 16-associated Cancer, Duane Sewell, Philadelphia
Oral #: 17 The Insulin-like Growth Factor-1 Receptor in Squamous Cell Carcinoma of the Head and Neck, Mark Jameson, Charlottesville
Oral #: 18 Over-expression of CLDN1 in oral carcinoma and its correlation with EGFR activation, Suzanne Kamel-Reid, Toronto
Discussion
Oral Session 4: 10:10 am – 11:00 am
Oral #: 19 IRX-2 Immunotherapy of Head and Neck Cancer, John Hadden, Farmingdale
Oral #: 20 In Vivo Optical Coherence Tomography of the Human Oral Cavity and Oropharynx, James Ridgway, Irvine
Oral #: 21 The Role of PET/CT Fusion in the Staging and Management of Primary Head and Neck Cancers, Alia Hdeib, Baltimore
Discussion
Oral #: 22 Headpin: An Endogenous and Exogenous Suppressor of Angiogenesis in HNSCC, Thomas Shellenberger, Houston
Oral #: 23 Tobacco Smoke Activates the EGFR Signaling Through Activation of the Protooncogene C-SRC, Dimitrios Moraitis, New York
Discussion
Oral Session 5: 3:00 pm – 4:40 pm
Oral #: 24 Quality of life after total laryngectomy, Rehan Kazi, London
Oral #: 25 Supraglottic and Supracricoid laryngectomy for advanced larynx cancer, David Goldenberg, Baltimore
Oral #: 26 Transoral laser surgery for pharyngeal or pharyngo-laryngeal carcinomas, Jürg Kutter, Lausanne
Oral #: 27 Mature Results of Phase II Multi-institute RADPLAT for T4 HNSCC (RTOG 9615), K. Thomas Robbins, Springfield
Discussion
Oral #: 28 Neck Dissection Impairment Index: A Disease Specific Measure Used to Evaluate Impairment After Neck Dissection, Douglas Chepeha, Ann Arbor
Oral #: 29 Twelve-year Experience with the Multimodal Intensification Regimen for Advanced Resectable Squamous Cell Cancer of the O, Enver Ozer, Columbus
Oral #: 30 Standardized Care Protocol for Alcohol Withdrawal in Post-operative Head and Neck Cancer Patients, Christopher Lansford, Ann Arbor
Discussion
Oral #: 31 Levels of the Major Urinary Metabolite of PGE2 (PGE-M) are Increased in Smokers. Evidence for a Noninvasive Biomarker., Neil Gross, New York
Oral #: 32 Pituitary Tumor Transforming Gene (PTTG) Induces Genomic Instability in Thyroid Cancer., Dae Kim, Birmingham
Discussion
AHNS
2005 Annual Meeting Support
PLATINUM LEVEL SUPPORT
Merck
SILVER LEVEL SUPPORT
Pentax Medical Company
Stryker Leibinger
BRONZE LEVEL SUPPORT
Fanconi Anemia Research Fund, Inc.
Karl Storz Endoscopy
Support as of March 1, 2005
|
